Introduction
The Copper Metabolism Murr1 Domain-containing protein 1 (COMMD1) is the founder member of a relatively new family of proteins, the COMMD family [1] . This protein family is distinguished by a unique motif called the COMM domain, located at their carboxyterminus. Recent studies have demonstrated that COMMD1 acts in a wide variety of cellular processes, including hepatic copper transport [2, 3] , hypoxia response [4] [5] [6] , sodium, potassium and chloride transport [7] [8] [9] [10] , and in nuclear factor kappa B (NF-κB) signaling [11] . We recently confirmed its role in hepatic copper homeostasis in liver-specific Commd1 knockout mice [12] . On depletion of Commd1 in hepatocytes, mice become susceptible to hepatic copper accumulation [12] , similar to dogs carrying a homozygous COMMD1 loss-of-function mutation [2] . Notwithstanding its role in copper transport, the biological role of COMMD1 in NF-κB signaling in the liver and in inflammatory liver diseases has not yet been defined.
The NF-κB family of transcription factors plays a key role in the inflammatory responses. The family consists of five members, of which p65 (RelA) and p50/p105 (NF-κB1) compose the canonical NF-κB pathway. The p65/p50 heterodimer is sequestered in the cytoplasm by the inhibitory IκB proteins. Activation of the canonical NF-κB pathway via the kinase complex IKK results in translocation of p65/p50 dimer to the nucleus for transcriptional activation of its target genes. COMMD1 has been shown to terminate NF-κB activity by acting as a scaffold protein in the E3 ubiquitin ligase complex (ECS SOCS1 ) [l,13] . ECS SOCS1 promotes ubiquitination and subsequent proteasomal degradation of p65 and destabilizes the interaction between p65 and chromatin. Hence, depletion of COMMD1 results in elevated p65 levels and subsequently increased NF-κB activity [1, 13, 14] .
The NF-κB signaling pathway has a remarkable physiological function in several liver diseases, including non-alcoholic fatty liver disease (NAFLD) [15] . NAFLD consists of a wide spectrum of pathologies, ranging from simple steatosis to non-alcoholic steatohepatitis (NASH), and can even progress to liver fibrosis and cirrhosis, and in some cases to hepatocellular carcinoma (HCC) [16] . The progression to the severe stages of NAFLD, which are related to a poor prognosis, is thought to be driven by inflammation, including the expression of the NF-κB-mediated cytokines Il-6 and Tnf-α [16] [17] [18] . These proinflammatory cytokines are mainly secreted by activated Kupffer cells, the resident liver macrophages, and they promote the progression of NAFLD towards NASH [19, 20] . In addition, the NF-κB signaling pathway in hepatocytes also plays a role in NAFLD progression, as hepatocyte-specific depletion of NEMO, the regulatory subunit of the IKK complex, results in chronic steatohepatitis and eventually leads to the formation of liver tumors [21] . Together these findings underscore the pivotal role of the NF-κB signaling pathway in health and disease, but the contribution of COMMD1 in hepatocyte NF-κB signaling and in inflammatory liver diseases still remains elusive. To determine the cell-type-specific role of COMMD1 in liver inflammation, we used hepatic and myeloid-specific Commd1-deficient mice and a second mouse model of NAFLD for lowgrade, chronic liver inflammation. In these different mouse models, we studied the level of diet-induced liver inflammation and the progression of hepatic steatosis.
Materials and methods

Animals
Conditional hepatocyte-specific (Commd1 ΔHep ) [12] and conditional myeloid-specific knockout mice (Commd1 ΔMye ) were obtained by crossing Commd1 loxP/loxP mice (here referred to as wild type (WT) mice) with Albumin-Cre [22] or LysM-Cre [23] transgenic mice, respectively. Both Commd1 ΔHep and Commd1 ΔMye mice were backcrossed in a C57BL/6J background for more than 8 generations. Commd1 loxP/loxP littermate mice (WT) served as controls for Commd1 ΔHep and Commd1 ΔMye mice. p55 Δns/Δns ; Commd1 ΔHep were obtained by crossing p55 Δns/Δns [24] with Commd1 ΔHep mice. All the experimental mice were males and were housed individually. They were fed ad libitum with either standard rodent chow diet (RMH-B, AB Diets, Woerden, The Netherlands), or, starting at 8-10 weeks of age, a high-fat, high-cholesterol (HFC) diet (45% calories from butter fat) containing 0.2% cholesterol (SAFE Diets) for a period of 12 weeks. p55 Δns/Δns ; Commd1 ΔHep and p55 Δns/Δns mice were fed only a chow diet and were sacrificed at the age of 20 weeks. All animals were sacrificed following a 4-hour morning fasting period. Body weight and liver weight measurements were recorded. Collected tissues were snap-frozen in liquid nitrogen and blood was collected by means of heart puncture in K3EDTA-coated MiniCollect® tubes (#450476, Greiner Bio-One, Alphen a/d Rijn, The Netherlands). The right hepatic lobe was used for gene expression, immunoblot and histological analysis. Plasma was separated by centrifuging at 3000 rpm for 10 min. at 4°C. All animal-related studies were approved by the Institutional Animal Care and Use Committee of the University of Groningen (Groningen, The Netherlands).
Liver nuclear and cytosolic fraction isolation, DNA binding ELISA
Fractionation was performed on fresh, ice-cold, mouse liver samples, using the Nuclear Extract Kit (#40010, Active Motif, La Hulpe, Belgium) according to the manufacturer's instructions. To study the activity of NF-κB in fresh livers, the DNA binding of p65 was assessed using the TransAM NF-κB p65 ELISA kit (#40096, Active Motif, La Hulpe, Belgium) according to the manufacturer's instructions.
Isolation of bone marrow cells and peritoneal macrophages
Bone marrow cells isolated from either WT or Commd1 ΔMye mice were cultured and differentiated into macrophages, as described previously [25] . Peritoneal macrophages were isolated 3 days after injection of 4% thioglycolate in the peritoneal cavity of either WT or Commd1 ΔMye mice.
Immunoblot analysis
Tissues were homogenized in NP40 buffer [0.1% Nonidet P-40 (NP-40), 0.4 M NaCl, 10 mM Tris-HCl (pH 8.0), 1 mM EDTA] supplemented with protease and phosphatase inhibitors and 30 μg of protein was loaded per gel lane. Samples were separated using sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) and transferred to Amersham™ Hybond™-P PVDF Transfer Membrane (#RPN303F, GE Healthcare, Diegem, Belgium). Bands were visualized using ChemiDoc™ XRS+ System (Bio-Rad Laboratories BV, Veenendaal, the Netherlands).
Liver lipid extraction
15% (w/v) liver homogenates were prepared in 1× PBS and lipid extraction was performed using the Bligh & Dyer method [26] . Samples were analyzed for cholesterol and triglyceride content.
Cholesterol and triglyceride analysis in plasma and liver lipid samples
Total cholesterol (TC) levels were determined using a colorimetric assay (11489232, Roche Molecular Biochemicals) with cholesterol standard FS (DiaSys Diagnostic Systems Gmbh, Holzheim, Germany) as a reference. Triglyceride (TG) levels were determined using Trig/GB kit (1187771, Roche Molecular Biochemicals) with Roche Precimat Glycerol standard (16658800) as a reference.
Antibodies
In these experimental procedures we used the following antibodies: rabbit polyclonal antibody against COMMD1 (11938-1-AP, Proteintech Group, USA), mouse anti-β-Actin (A5441, Sigma-Aldrich Chemie B.V., Zwijndrecht, The Netherlands), rabbit anti-Tubulin (AB4047, Abcam, Cambridge, UK), rabbit anti-Lamin A/C (2032, Cell Signaling Technology Europe, B.V., Leiden, The Netherlands), rabbit anti-p65 (4764, Cell Signaling Technology, Europe, B.V.), rabbit anti-IκBα (sc-371, Santa Cruz Biotechnology Inc., Heidelberg, Germany), rabbit anti-Cd68 (#137002, Biolegio, Nijmegen, The Netherlands) rabbit anti-F4/80 (#101201, Biolegio, Nijmegen, The Netherlands), goat anti-rabbit IgG (H + L)-HRP Conjugate (170-6515, Bio-Rad Laboratories BV, Veenendaal, The Netherlands), goat anti-mouse IgG (H + L)-HRP Conjugate (170-6516, Bio-Rad Laboratories BV).
Liver histology
Paraffin-embedded liver sections (4 μm) were stained with hematoxylin & eosin (H&E). Snap-frozen liver sections (5 μm) were stained using Oil Red O (ORO) or antibodies against Cd68. F4/80 staining was performed on either paraffin-embedded or snap-frozen liver sections. Scoring of steatosis and lobular inflammation was performed in an unbiased manner by an experienced, certified veterinary pathologist using a method described previously [27] .
Gene expression analysis
Pieces of murine liver of approximately 100 mg were homogenized in 1 ml QIAzol Lysis Reagent (Qiagen, Venlo, The Netherlands). Total RNA was isolated by chloroform extraction. Isopropanol-precipitated and ethanol-washed RNA pellets were dissolved in RNase/DNase free water. 1 μg of RNA was used to prepare cDNA with the Quantitect Reverse Transcription Kit (Qiagen, Venlo, The Netherlands) according to the protocol provided by the manufacturer. 20 ng cDNA was used for subsequent quantitative real-time PCR (qRT-PCR) analysis using iTaq SYBR Green Supermix with ROX (Bio-Rad Laboratories BV) and 7900HT Fast Real-Time PCR System (Applied Biosystems). The following PCR program was used: 50°C/2 min., 95°C/10 min., 40 cycles of 95°C/15 s and 60°C/1 min. Expression data were analyzed using SDS 2.3 software (Applied Biosystems) and the standard curve method of calculation. Mouse Cyclophilin A was used as an internal control gene. The primer sequences we used are listed in Table S1 .
Statistical analysis
All results are expressed as mean ± SEM. Statistical analysis was performed using Prism 5.00 for Windows (GraphPad Software, CA, USA) and the unpaired Student's t test. Results of P b 0.05 were considered to be statistically significant.
Results
Hepatic depletion of Commd1 results in increased levels of NF-κB subunit p65
To elucidate the role of hepatic Commd1 in NF-κB signaling and inflammation in vivo, we depleted Commd1 in hepatocytes (Commd1 ΔHep ) by crossing Commd1 loxP/loxP mice with Alb-Cre transgenic mice, mice expressing Cre-recombinase in adult hepatocytes [12] . Commd1 ΔHep mice showed marked reduction in hepatic Commd1 levels, however some residual amount of Commd1 was detected ( Fig. 1A) , which is likely due to the expression of Commd1 in nonparenchymal cells, as approximately 80% of an adult liver genome exists in hepatocytes, the rest is located in endothelial, stellate or Kupffer cells [28] .
Since various cellular models demonstrated that down-regulation of COMMD1 results in elevated p65 levels and subsequently increased NF-κB activity [1, 13] , we first assessed the levels of p65 in nuclear and cytosolic fractions of livers from WT (n = 6) and Commd1 ΔHep mice (n = 6-8) ( Fig. 1A ). We observed that Commd1 ΔHep mice showed clearly higher protein levels of p65 in both the cytosolic and nuclear fractions of livers compared with WT mice.
Next, we determined whether the rise in protein p65 levels was caused by an increase in p65 mRNA levels ( Fig. 1B) . We detected no difference in hepatic p65 gene expression between Commd1 ΔHep mice and WT littermates, excluding the possibility that the increase in p65 protein levels was due to alterations in transcriptional regulation. In line with previous in vitro studies [1, 13] , these data suggest that Commd1 depletion results in an increased protein stability of p65 in hepatocytes.
Hepatic Commd1 depletion aggravates steatosis, but not inflammation
Since NF-κB-mediated inflammation is associated with the progression of NAFLD towards a more severe NASH phenotype [29] [30] [31] , we investigated the consequences of elevated p65 levels in hepatic Commd1deficient mice on inflammation in a mouse model of NAFLD induced by an HFC diet. After 12 weeks of HFC feeding, we saw no differences in body and liver weight between Commd1 ΔHep and WT mice ( Fig. 2A ). In addition, no liver damage was observed, as the plasma levels of the liver enzymes ALT and AST were not markedly increased (data not shown). Surprisingly however, total hepatic cholesterol and triglyceride levels were significantly increased in the Commd1 ΔHep mice following 12 weeks of HFC diet (Fig. 2B ). This observation was supported by histological analysis: hematoxylin and eosin (H&E) staining demonstrated an increase in lipid deposits in the livers of Commd1 ΔHep mice (Fig. 2C , D), as confirmed by ORO staining (Fig. 2C ). These differences were not seen in chow-fed animals. Histologically, HFC-feeding markedly increased the level of lobular inflammation in both WT and Commd1 ΔHep mice, but no alterations between the genotypes were seen ( Fig. 2E) .
In order to investigate the effect of Commd1 loss in hepatocytes on inflammation in greater detail, we performed immunohistochemical stainings. Immunostaining for the macrophage markers [32] Cd68 (a marker of activated macrophages [33] ) and F4/80 (marker of mature macrophages, highly expressed by Kupffer cells [33] ) showed increased infiltration of macrophages in the livers on HFC feeding (Fig. 3A ), but we saw no differences between Commd1 ΔHep and WT mice. Expression analysis of Cd68 and F4/80, together with Cd11b, a migratory marker of blood-derived monocytes [34] , confirmed the immunohistochemical results ( Fig. 3B ).
Next, hepatic mRNA levels of a number of NF-κB target genes were determined ( Fig. 3C ). A significant increase in the expression of the proinflammatory genes: Tnfα, Il-1α, Il-1β and Mcp1, and the NF-κB target genes: Icam, and Tnfaip3 (A20) was detected following 12 weeks of HFC feeding, but we saw no differences between Commd1 ΔHep and WT mice, corroborating the histological analysis. In addition, no substantial difference in the expression of other NF-κB (Fig. S1A) or Commd genes was seen ( Fig. S1B ). Altogether, hepatic deficiency of Commd1 exacerbated HFC diet-induced steatosis, but not liver inflammation. Since Commd1 is involved in multiple physiological processes [3, 11, 35] , it is possible that dietary intervention in combination with Commd1 deficiency affects additional pathways that modulate dietinduced liver inflammation, independent of its role in NF-κB signaling, leading to the observed results. Therefore, we decided to use a genetic approach to further evaluate the role of hepatocyte Commd1 in NF-κBmediated liver inflammation. We crossed Commd1 ΔHep mice on a p55 Δns/Δns genetic background (p55 Δns/Δns ; Commd1 ΔHep ). The p55 Δns/Δns mice are homozygous for a mutation in the gene encoding the tumor necrosis factor receptor 1 (Tnfr1). This mutation results in impaired shedding of the Tnfr1 from the cell surface, resulting in increased activation of NF-κB and chronic, low-grade inflammation in the liver [24, 36] . The p55 Δns/Δns ; Commd1 ΔHep mice were born without any overt phenotype and in the expected Mendelian ratios. No differences in body and liver weight were observed (Fig. 4A, B) . In line with the phenotype of Commd1 ΔHep mice, hepatic Commd1 ablation in p55 Δns/Δns mice also resulted in elevated levels of p65 (Fig. 4C) , with no alteration in p65 mRNA levels (Fig. 4D ). Furthermore, similar to what we and others have previously shown [24, 36] , p55 Δns/Δns mice display a significant increase in the number of inflammatory foci within hepatic lobules (Fig. 4E ). However, we saw no clear differences in the number of inflammatory foci between p55 Δns/Δns (n = 6) and p55 Δns/Δns ; Commd1 ΔHep mice (n = 7) ( Fig. 4E ). This observation was corroborated by the fact that the gene expression of proinflammatory markers and cytokines was not affected by Commd1 deficiency (Fig. 4F ). Only Il-1α mRNA levels were significantly increased, but the level of induction was rather mild. In addition to the NF-κB signaling pathway, TNF-α also activates apoptotic pathways [37, 38] , and since NF-κB drives the expression of antiapoptotic genes, we also looked at the mRNA levels of anti-apoptotic genes mediated by NF-κB ( Fig. 4G ). However, we saw no differences between the two groups (Fig. 4G) .
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Altogether, using two independent but complementary approaches, we showed that depletion of Commd1 in hepatocytes leads to elevated levels of the NF-κB subunit p65, both in the nucleus and cytoplasm, but that it does not affect the level of liver inflammation induced by HFCfeeding nor in Tnf-mediated chronic hepatitis. 
Steatosis and inflammation are exacerbated in myeloid-deficient Commd1 mice
In addition to hepatocytes, myeloid cells (in particular macrophages) also play a crucial role in NF-κB-mediated liver inflammation and in the progression of NAFLD [39] . We therefore assessed the role of myeloid Commd1 in liver inflammation during the development of steatohepatitis. We crossed mice carrying floxed conditional Commd1 alleles with LysM-Cre transgenic mice [23] to specifically ablate Commd1 in the myeloid lineage ( Fig. S2A,B) [40] . We fed WT (n = 6-7) and Commd1 ΔMye mice (n = 6-7) either chow or HFC diet for 12 weeks. Commd1 deficiency in myeloid cells did not lead to differences in body and liver weight, neither in chow-nor HFC-fed mice (Fig. 5A) . The plasma levels of the liver enzymes ALT and AST were also not noticeably elevated (data not shown). However, HFC-fed Commd1 ΔMye mice showed a significant increase in liver triglyceride levels compared to WT mice (Fig. 5B) . H&E staining of the livers corroborated the exacerbated liver steatosis in Commd1 ΔMye mice, and was further confirmed by ORO staining (Fig. 5C, D) .
In addition to the elevated hepatic fat deposits, histological scoring also revealed an increase in hepatic inflammation (Fig. 5E ). The microscopic appearance of the livers showed inflammatory foci widespread in the hepatic tissue. We therefore investigated the effect of myeloid Commd1 depletion on liver inflammation in more detail. We stained liver sections of Commd1 ΔMye and WT mice for Cd68 and F4/80 (Fig. 6A) . Histological scoring showed an increase in the number of inflammatory foci in Commd1 ΔMye mice following 12 weeks of HFC feeding. Moreover, this observation was confirmed by mRNA expression analysis (Fig. 6B ). In addition, we analyzed the expression of various proinflammatory cytokines regulated by NF-κB, such as Tnf, Mcp-1, Ccl5 and Icam (Fig. 6C ). Dietary intervention markedly induced the expression of proinflammatory markers in both groups. Compared to WT mice, Commd1 ΔMye mice showed a significant increase in mRNA expression of most of the proinflammatory markers studied, except for Cd11b and Ccl5, which both showed a trend towards elevated expression ( Fig. 6B, C) . In conclusion, depletion of Commd1 in myeloid cells leads not only to increased liver inflammation, but also exacerbates the progression of steatosis upon 12 weeks of HFC feeding.
Discussion
NF-κB signaling is an essential pathway in the progression of many inflammatory diseases, including NAFLD [41, 42] . It is therefore crucial to identify the genes and mechanisms regulating the NF-κB pathway, and these might lead to novel therapeutic strategies to treat NAFLD. COMMD1, a pleiotropic protein, is involved in various pathways including NF-κB signaling [1, 11] . Here we evaluated the extent that Commd1 deficiency in either hepatocytes or macrophages contributes to liver inflammation and progression of NAFLD in mice. On the one hand we showed that Commd1 has a cell-type-specific role in controlling liver inflammation in NAFLD, since myeloid Commd1 deficiency, but not hepatocyte-specific deletion, augmented the inflammatory tone of the disease. On the other hand, we saw that depletion of Commd1 in either cell type exacerbated diet-induced hepatic lipid accumulation.
Ablation of Commd1 in the myeloid lineage caused increased dietinduced steatosis and liver inflammation concomitant with the elevated expression of several inflammatory cytokines, in particular Tnfα. Kupffer cells are the main source of hepatic TNFα, which has been shown to be an essential cytokine in the progression of NAFLD [39] . Blocking the 
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ΔHep (HFC) WT (HFC) Tnfα signaling pathway by deletion of either the Tnfr1 or Tnfα ameliorates NAFLD in mice [20, 43, 44] . In addition, leptin-deficient (Ob/Ob) mice treated with anti-TNFα antibodies show a reduced level of liver steatosis [45] [46] [47] . The increased lipid accumulation observed in HFCfed Commd1 ΔMye mice might therefore be explained by the elevated Tnfα expression in these mice. Our observation of a higher inflammatory tone in the liver of HFC-fed Commd1 ΔMye mice is in line with our recent study [40] , in which we showed that myeloid depletion of Commd1 exacerbates dextran sodium sulfate (DSS)-induced colitis and increases the susceptibility to sepsis because it invokes a stronger inflammatory response. Furthermore, Commd1 deficiency in bone-marrow derived myeloid cells selectively altered the expression of LPS-mediated genes, including a subset of genes involved in the immune response, and genes directly regulated by NF-κB [40] . However, these expression data also demonstrated that in addition to NF-κB, myeloid Commd1 also mediates other pathways activated by LPS, either directly or indirectly [40] . In addition, the intestinal epithelial-deficient Commd1 mice do not show increased inflammation or any sensitivity difference in DSS-induced colitis, resembling some aspects of the hepatic-specific deficiency that we present here.
Despite the elevated levels of cytosolic and nuclear p65 (Fig. 1A) , Commd1 deficiency in hepatocytes did not affect the level of liver inflammation in either NAFLD (Fig. 3 ) or in mice with low-grade liver inflammation due to a mutation in Tnfr1 [24, 36] . Nonetheless, the increase in p65 levels is in line with previous in vitro studies [1, 13] , which demonstrated that COMMD1 promotes the ubiquitin-mediated proteolysis of p65. Insufficiency of COMMD1 in U2OS cells [13] or loss of p65-COMMD1 interaction [14] increased the steady-state and the protein stability of p65, respectively. Together with the unchanged mRNA levels of p65 (Fig. 1B) , these data suggest that the elevated p65 levels in Commd1-deficient hepatocytes may result from an increased protein stability of p65 caused by reduced p65 ubiquitination. Nevertheless, independent of the level of hepatocyte p65, the activity of NF-κB is not changed upon depletion of Commd1 (Fig. 3C) . A DNA-binding ELISA assay to assess the activity of NF-κB supported this observation. Although LPS injection itself significantly increased the activity of NF-κB in the livers of WT and Commd1 ΔHep mice, Commd1 deficiency did not affect the level of NF-κB binding to DNA neither after PBS nor LPS (Fig. S3 ). The level of NF-κB activity is tightly titrated through various mechanisms [48] [49] [50] [51] [52] [53] and numerous proteins controlling NF-κB signaling have been identified [11] ; we therefore speculate that the effect of Commd1 loss is compensated for by another mechanism to restore a basal NF-κB activity. We excluded the contribution of the well-known NF-κB inhibitors, IκBα (Nfkbia) and A20 (Tnfaip3) [11] . NF-κB drives the expression of both genes, but the mRNA levels of IκBα (Nfkbia) and A20 (Tnfaip3) in Commd1 ΔHep livers of chow-and HFC-fed mice were not altered compared to WT mice (Fig. 3C ). In line with this observation, we saw no difference in IκBα (Nfkbia) protein levels in p55 Δns/Δns ; Commd1 ΔHep mice (Fig. 4C ). In addition, we saw no marked differences in the expression of other COMMD genes, a family of proteins, which have the ability to inhibit NF-κB activity [1, 11] . This suggests that there is another homeostatic mechanism that prevents uncontrolled NF-κB activity in Commd1-deficient hepatocytes, which requires further studies to identify the mechanism and understand what is happening. Despite the lack of a higher inflammatory response, Commd1 ΔHep mice fed a HFC-diet surprisingly showed elevated levels of liver cholesterol and triglycerides (TG) compared to WT littermates (Fig. 2B) . Supported by histological analysis, these data indicate that hepatic Commd1 deficiency aggravates steatosis. Although COMMD1 has been linked to the regulation of biliary copper excretion and may regulate trafficking of various transporters [2, 9, 54] , including ATP7B, a P-type ATPase which mediates copper excretion into the bile [55] , we could not observe any marked changes in the biliary cholesterol excretion determined by the in vivo Transintestinal Cholesterol Excretion (TICE) experiment [56] (data not shown). Because we did not observe any marked changes in the mRNA levels of various genes involved in lipid uptake, synthesis and excretion (data not shown), a clear explanation for this observation is still missing. However, as COMMD1 is associated with the intracellular trafficking of various proteins and is localized to vesicles (reviewed in [3] ), we speculate that COMMD1 acts as an adaptor protein in sorting/fusion of vesicles, a process that is also involved in autophagy. Recent studies demonstrated that inhibition of macroautophagy is associated with accumulation of TG and cholesterol in lipid droplets [57, 58] . It would therefore be of interest to further investigate the hepatic function of COMMD1, and to determine which kind of vesicles COMMD1 is localized to. Although COMMD1 partially co-localizes to endosomal and lysomal markers (reviewed in [3] ), COMMD1-associated vesicles are still not fully characterized. Based on its pleiotropic function, it is highly possible that COMMD1 is not only involved in biliary copper excretion, but requires further substantial investigation.
In conclusion, in this study we demonstrate that Commd1 represses the level of inflammation in NAFLD in a cell-type-dependent manner. Although hepatocyte Commd1 does not play a major role in liver inflammation, our data indicate that it does have a protective role in slowing the progression of steatosis in mice. Furthermore, our current knowledge advocates that its repressive action on inflammation is restricted to myeloid cells and this seems to be a general phenomenon in various disease models [40] . The mechanism by which myeloid COMMD1 restrains inflammation might therefore be an interesting target for developing new treatment strategies for inflammatory diseases.
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